MMR: Risk, choice, chance

British Medical Bulletin

Volumn 69, Issue , 2004, Pages 143-153

  Fitzpatrick, Michael ^a  

^a Barton House Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

AUTISM; CULTURAL FACTOR; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; MASS IMMUNIZATION; MEASLES; MUMPS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RUBELLA; UNITED KINGDOM; VACCINATION;

HEALTH CARE AND PUBLIC HEALTH;

ATTITUDE TO HEALTH; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; PARENTAL CONSENT; PREVALENCE; RISK ASSESSMENT; UNITED STATES;

EID: 3142661067     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/ldh002     Document Type: Review

References (35)

1. Fitzpatrick M. MMR and Autism: What Parents Need to Know. London: Routledge, 2004
2. Wakefield AJ, Murch SM, Anthony A, Linnell DM, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-41
3. Taylor B, Miller E, Farrington CP, Petropoulos M-C, Favot-Mayaud I, Li J, Waight PA. Autism and MMR vaccine: no epidemiological evidence for a causal association. Lancet 1999; 353: 2026-9
4. Farrington CP, Miller E, Taylor B. MMR and autism: further evidence against a causal association. Vaccine 2001; 19: 3632-5
5. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. MMR vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002; 324: 393-6
6. Dales L, Hammer S, Smith N. Time trends in autism and in MMR immunisation coverage in California. JAMA 2001; 285: 1183-5
7. Kaye JA, del Mar Melero-Montes M, Jick H. MMR vaccine and the incidence of autism recorded by GPs: a time-trend analysis. BMJ 2001; 322: 460-3
8. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. No evidence for MMR vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998; 351: 1327-8
9. Patja A, Davidkin I, Kurki T, Kallio MJT, Valle MHP. Serious adverse events after MMR vaccination during a 14-year prospective follow-up. Pediatr Infect Dis J 2000; 19: 1127-34
10. Madsen KM, Hvidd A, Vestergaard M, Schendel D, Wohlfart J, Thorsen P, Olsen J, Melbye M. A population-based study of MMR vaccine and autism. N Engl J Med 2002; 347: 1477-82
11. Wakefield AL. Press Release, 6 November 2002, Visceral (http://www.visceral.org.uk)
12. Phillips M. MMR: the truth, Daily Mail, 11 March 2003, 43
13. Miller E, Waight P, Farrington CP, Andrews N, Stowe J, Taylor B. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001; 84: 227-9
14. Uhlmann V, Shiels O, Wakefield AJ, O'Leary J. Potential viral pathogenic mechanism for new variant IBD. J Clin Pathol Mol Pathol 2002; 55: 84-90
15. O'Leary JJ. Link found between measles virus and gut abnormalities in children with developmental disorder (press statement), February 2002 (http://mp.bmjjournals.com/cgi/content/full/54/DC1)
16. Wakefield AJ. Testimony of Dr Andrew J Wakefield, Committee on Government Reform (US House of Representatives) June 2002 (http://www.house.gov/reform/ hearings/healthcare/02.06.19/wakefield.htm)
17. O'Leary JJ. Neither this publication nor any public presentation by me or my research team has stated that MMR causes autism (press statement), 16 June 2002 (http://www.mmrthefacts. nhs.uk/news)
18. Shiels O, Smyth P, Martin C, O'Leary JJ. Development of an 'allelic discrimination' type assay to differentiate between the strain origins of measles virus detected in intestinal tissue of children with ileocolonic lymphonodular hyperplasia and concomitant developmental disorder. Abstract (No 20) presented at Pathological Society of Great Britain and Ireland, 2002 (http://www.pathsoc.org.uk/meet/prog.shtml)
19. Brown DWG, Jin L, Ramsay M. Comments on abstract submission, Infectious Diseases in the News, London: Public Health Laboratory Service, 27 June 2002 (http://www.phls.org.uk/press)
20. Peckham C. National Immunisation Study: Factors Influencing Immunisation Uptake in Childhood (Peckham Report). London: Institute of Child Health/Action Research for the Crippled Child, 1989
21. Hargreaves I, Lewis J, Speers T. Towards a Better Map: Science, the Public and the Media. London: Economic and Social Research Council, 2003
22. National Autistic Society. MMR: the NAS position (press statement), 12 March 2002 (http://www.nas.org.uk/)
23. Rogers A, Pilgrim D. Rational non-compliance with childhood immunisation: personal accounts of parents and primary health care professionals. In: Health Education Authority (eds) Uptake of Immunisation: Issues for Health Education. London: Health Education Authority, 1994
24. Offit P. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 2002; 109: 124-9
25. Fombonne E, Chakrabarti S. No evidence for a new variant of MMR-induced autism. Pediatrics 2001; 108: e58 (http://pediatrics.org/cgi/content/full/108/4/ e58)
26. Gillberg C, Steffenburg S, Schaumann H. Is autism more common now than ten years ago? Br J Psychiatry 1991; 158: 403-9
27. Wing L. Autistic spectrum disorders: no evidence for an increase in prevalence. BMJ 1996; 312: 327-8
28. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev 2002; 8: 151-61
29. Rimland B. The DAN! Philosophy, 2002 (www.autism.com/ari/danstatement. html)
30. Shattock P. Back to the future: an assessment of some of the unorthodox forms of biomedical intervention currently being applied to autism, paper presented at the Durham Conference 1995 (http://osiris.sunderland.ac.uk/autism/ durham95.html)
31. Shattock P, Savery D. Autism as a Metabolic Disorder. Sunderland, UK: Autism Research Unit, 1997
32. Shaw W. Biological Treatments for Autism and PDD. Kansas, USA: Great Plains Laboratory, 2002
33. Chaitow L. Vaccination and Immunisation: Dangers, Delusions and Alternatives (What Every Parent Should Know). Saffron Walden: Daniel, 1987
34. Rogers A, Pilgrim D. The risk of resistance: perspectives on the mass childhood immunisation programme. In: Gabe J (ed.) Medicine, Health and Risk: Sociological Approaches. Oxford: Blackwell, 1995
35. Orenstein AO, Hinman AR. The immunisation system in the United States-the role of school immunisation laws. Vaccine 1999; 17: S9-S24